This white paper offers guidance on implementing remote assessment for studies operating during the COVID-19 crisis. Signant Health experts, Dan Debonis and Gary Sachs, discuss methods to collect data that will identify where and how remote ratings are used. They also offer principles to maximize the quantity and quality of data even while operating under conditions of uncertainty.

Learn about the important considerations regarding:

• Legal & regulatory needs
• Operations
• Clinical requirements
• Logistics
• Safety
• Engagement